Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Next BAWA talk and coffee morning

    New research explained: Ryan Edgington is to talk to us at BAWA, Filton, on November 8 about the RaNT (Raman Nanotheranostics) progrmme. It is a £5.7m project developing a new technique which aims to detect and treat cancers non-invasively, using tiny, specially-designed gold particles and infra-red laser light. Learn more here  OUR September BAWA meeting heard a Zoom talk by David James, Head of Patient Projects, Prostate Cancer Research. Hear a recording of the talk via this link. The next coffee morning will be on November 4, 10am to noon. It will be at the Penny Brohn centre, Chapel Pill Lane, Pill, BS20 0HH. Next year our walks will be around Clapton-in-Gordano on April 1 and the autumn one will be around Ashton Court on October 7.

    Tim Bond, below, was elected chairman of Prospect at the 2021 AGM. He replaces Malcolm Gamlin, who retired after 13 years in the role. Malcolm was thanked for his hard work. Mick Broggio resigned as secretary but volunteer Martin Webb was co-opted by the committee in July and elected at the AGM. Other committee members were re-elected at the AGM too.

    E-cycling for men with PCa

    At BAWA on January 10 Jessica Bourne of Bristol University is to give an overview of an e-cycling study designed for cancer survivors. The researchers want to find out if people recovering from breast cancer and PCa are interested in using e-cycles to increase their physical activity. Jessiica will bring cycling instructors too, to hear our experience of living with cancer so that they can gain a better understanding of the condition.

    PSA tests for some over-40s?

    Some men should have annual prostate checks after 40 to spot early, treatable cancers, UK experts say. Targeted PSA screening would save lives, the Institute of Cancer Research team says, even though that blood test is not accurate enough to offer more widely. The idea was trialled in men at high genetic risk for certain cancers (Oct ’21). More here

    Look Good Feel Better workshops

    The Look Good Feel Better workshops for men might be of interest to members. They invite men for a relaxed online session on November 2 from 10am to noon. The workshops not only offer some great skincare and grooming advice from experts but also include a guest speaker each month talking about the various ways they can help support men living with cancer. To book click here

    Why hormone therapies fail

    Studying the cellular metabolism of PCa, a team of US researchers identified a key reason hormone therapies eventually fail, while also laying out a way to bypass the problem using an entirely new therapeutic approach (Oct ’21). More here

    Nutrition and prostate cancer

    A video of the Prostate Cancer Research webinar session on this subject is available on demand at pcr.org.uk/living-well-library/september A copy of the presentation is available at: https://www.pcr.org.uk/wp-content/uploads/2021/09/Prostate-Cancer-and-Nutrition-Webinar-1.pdf  For more information or how to contact the presenters visit https://www.functionalmedicinewimbledon.com

    Good news for advanced patients

    Apalutamide has been approved, Prostate Cancer UK reports. It means hormone treatment willl now be offered to those with advanced PCa who cannnot or should not receive chemotherapy as well as those who have become resistant to tranditional hormone therapies (Sept ’21).

    Test might detect 50 cancers

    NHS to trial ‘revolutionary’ blood test that can detect 50 types of cancer early (Sept ’21). See here

    Memorial to tour UK

    You can add a loved-one’s name to a Prostate Cancer UK memorial that will soon tour the UK. See how here

    Covid vaccine tech ‘could beat cancer’

    The Oxford-Astra Zeneca Covid vaccine technology has been used to design a jab that could treat cancer (Sept ’21). Sky News

    Enzalutamide (Xtandi) approved

    Important news from NICE for the 4,100 men each year who are unsuitable for the standard treatment of docetaxel chemotherapy and who have, until now, had limited treatment options (June ’21).  More here:

    Study into black men’s higher risk

    In partnership with Movember, Prostate Cancer UK is funding a study to help find out why black men are at higher risk of PCa than other ethnic groups. More here

    Research into advanced PCa

    Prostate Cancer Research is to fund five new research projects into advanced PCa. They will target signalling to stop cancer spread; target sugars to stop cancer spread; investigate the proteins that drive cancer spread and treatment resistance; develop software to predict which cancers will return and explore the link between fat and PCa.

    New vaccine ‘could prevent PCa’

    See here

    Dogs sniff out worst cancers

    Dogs can detect the most aggressive forms of PCa and could help develop a “robotic nose” to find the disease, a study says  (Feb ’21). More here. And another study suggests daily coffee drinking lowers PCa risk, (Feb ’21). More here

    Drugs to fight cancer resistance

    The world’s first drugs designed to stop cancer cells becoming resistant to treatment could be available within a decade, scientists have said (Jan ’21). More here

    Urine test detects PCa

    A new technique detects PCa with almost 100% accuracy within 20 minutes using only a urine sample (Jan ’21). More here

    Bone scan breakthrough

    A new bone scan technique can identify men with advanced PCa who’ll benefit from radiotherapy. This ground-breaking achievement could help extend the lives of 25-30% of such patients (Jan ’21). See more here

    Good news re Olaparib

    Olaparib has given new hope to men with incurable PCa, says the Daily Mail in this article.

    Big change in PCa diagnosis

    The biggest diagnostic development in PCa diagnosis for 50 years – that came about when NICE advised that all men at risk of PCa should have an MRI before a biopsy. The change has had a worldwide effect. See more here

    Check your risk in 30 seconds!

    An online 30-second risk checker has been launched which men are encouraged to take –  see here

    Good news on abiraterone

    NICE agreed to an appeal by Prostate Cancer UK to reverse its decision to restrict abiraterone for advanced PCa (Jul ’20). See more here. UK deaths from PCa exceeded 12,000 in 2019 for the first time and it overtook breast cancer as the most common cancer (June ’20). See more hereAnd a new type of immune cell which kills most cancers has been discovered. More info here  Screening: An expert explained why finding a suitable method is vital but is difficult. More here

  • Hormone treatment and Covid-19

    Hormone treatment might offer some protection from Covid-19, it’s reported. See more here But it can make PCa worse, this study finds.  An online survey aiming to shed more light on the experience of PCa patients on this therapy (aged 35 to 80) is being conducted via this link And a London college has developed an online intervention to support men with PCa who have ongoing fatigue, and it is recruiting patients to take part. Information here. And an oil-based oral formulation has been found that not only enables a smaller dose of abiraterone to be effective but also has the potential to dramatically reduce possible side effects (Jun ’20). See more here

  • Patient guide ‘good source of info’

    Prostate Cancer Foundation’s Patient Guide (updated to ’21) is said to be one of the best sources of information from diagnosis to survival of PCa. Download it for free here.  Our New Research page is updated regularly.

  • Drugs approved and a PCa ‘killer’

    The NHS confirmed that the chemotherapy drug docetaxel will be made available to PCa patients as soon as they are diagnosed instead waiting until other treatments stop working. See.  And NICE has approved a new drug, Darolutamide, as an option for treating hormone-relapsed PCa in men at high risk of developing metastatic disease. See more here Also scientists have found that a natural insecticide kills advanced PCa cells. See more here More news on the newsletter page.

RunningWe are a friendly and supportive network that meets at BAWA, Filton. Meeting details are in the column on the left. Our group aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us: 0800 035 5302. You can join us for a small subscription by filling in the PDF membership form on the Contact/Join us page.

This site has been compiled by PCa survivors. We don’t claim to have specialist knowledge other than that gained by PCa patients during their treatment.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties. The holder acts as a focal point for communications on region-specific topics between the new chairman, Ken Mastris, and member groups in the area. In addition, he or she will participate in occasional meetings or teleconferences. All expenses are reimbursed. If any Prospect member wishes to volunteer, they can email info@tackleprostate.org

Protected from despair…

George Monbiot writes in the Guardian that the principles that define a good life protect him from despair, despite a diagnosis of prostate cancer and the ‘grisly’ operation he faces (Mar ’18). See here

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Having the conversation…

“Manversation” is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form. Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website.

Myths debunked and spotting fake cancer news

Ten cancer myths debunked. See here. And also here are six tips to spot cancer fake news

New information for at-risk black men

One in four black men will get prostate cancer – double the overall risk faced by all UK men. Are you are risk? See here

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March ’17, recognises teams working together to deliver improved patient care and public health. See a video about their work here.

For more information on Energise see our Helpful links page.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See here. The charity also says PCa survival has tripled in the UK over the past 40 years. More than eight in 10 patients are alive ten years after diagnosis – up from one in four in the 1970s.

And we have more research news here.

Swedish test dropped

Swedish researchers found a test which showed promise and seemed much better than PSA alone at detecting potentially dangerous prostate cancers. But now Prostate Cancer UK says the Swedish test, while it has had some uptake in some Scandinavian countries, it has not seen the same uptake elsewhere. Prostate Cancer UK said it had initially intended to support some research towards its use in the UK, but this did not materialise and the field has advanced somewhat since then. It is considering a number of other options which could prove to be more effective than PSA as a diagnostic test, and as specified in its revised research strategy, it is intending large-scale investment to support the development of a screening programme for PCa. The charity hopes to be able to provide an update about this in due course.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See here

Cancer ‘as unique as fingerprints’

Each person’s cancer is as unique as their fingerprints, said Professor Gillies McKenna, Director of the CRUK/MCR Oxford Institute for Radiation Oncology. This created an opportunity for more precise treatment.

Back to top

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Exchange information

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Help with treatment choices

    Get enhanced guidance on treatment options, thanks to a checklist developed by researchers (Jun ’17). See. More help here. And why it’s difficult to choose among treatment options (Jul ’17). See. Men with early stage prostate cancer wishing to preserve sexual function while on treatment do not always make the right choices. See

  • Buddies home support hope

    This Macmillan service offered home-visit support for adult cancer patients in our areas and after Covid they are working on re-starting  face-to-face visits again towards the end of October. In the meantime the Bristol Buddies service has moved to its national telephone service. Ring 07543 248714 or see this site for support.